FDA Inspection 1122152 — New Hope Clinical Research
The FDA completed an inspection of New Hope Clinical Research on March 13, 2020 in Charlotte, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 13, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Charlotte, NC (United States)
Additional Details
Clinical BA/BE